Table 1 The results of MS/MS and GC/MS in neonatal period
DATE | Time | MS/MS | GC/MS | |||
|---|---|---|---|---|---|---|
C0 (10–50 μmol/L) | C3 (0.38–3.6 μmol/L) | C3/C2 (0.04–0.2) | C3/C0 (0.02–0.17) | 3-Hydroxypropionate (0–1.1) | ||
Patient 1 | At the time of diagnosis | 4.62↓ | 8.99↑ | 1.60↑ | 1.94↑ | 63.52↑ |
– | – | – | – | – | – | |
– | – | – | – | – | – | |
Patient 2 | At the time of diagnosis | 1.55↓ | 7.19↑ | 5.48↑ | 4.65↑ | 280.39↑ |
After 1 month of treatment | 3.22↓ | 5.54↑ | 3.21↑ | 1.72↑ | 70.55↑ | |
Latest | 4.23↓ | 6.13↑ | 1.82↑ | 1.45↑ | 30.21↑ | |
Patient 3 | At the time of diagnosis | 13.1 | 9.46↑ | 0.77↑ | 0.72↑ | 26.41↑ |
After 3 month of treatment | 14.5 | 7.34↑ | 0.65↑ | 0.51↑ | 24.63↑ | |
Latest | 13.59 | 7.26↑ | 0.81↑ | 0.63↑ | 25.12↑ | |